Education
| School — Major — Degree | Duration |
|---|---|
|
國防醫學院 — 生命科學研究所(畢) — 博士 Doctorate, Graduate Institute of Life Sciences, National Defense Medical Center |
2006/09 — 2012/01 |
|
長庚大學 — 醫學生物技術研究所(畢) — 碩士 Master, Department of Medical Biotechnology and Laboratory Science, Chang Gung University |
2003/09 — 2005/06 |
|
中山醫學大學 — 生命科學系(畢) — 學士 Bachelor, Department of Biomedical Sciences, Chung Shan Medical University |
1999/09 — 2003/06 |
Intramural Experience
| Office/Department/Institute | Position | Duration |
|---|---|---|
| 藥理學科 Department of Pharmacology | Assistant Professor | 2025/08/01 — |
Extramural Experience
| DEPNO | Position- Office/Department/Institute | Duration |
|---|---|---|
| 義大醫院醫學研究部 | 助理研究員 | 1100726 — 1140731 |
| 靜宜大學化粧品科學系 | 助理教授 | 1070801 — 1100725 |
Discipline
Research & Technology Platform Open to the Outside
Interested Area(s)for Interdisciplinary Research
發炎藥理學, 癌症藥理學, 腫瘤免疫微環境
Area(s) of Expertise & Research
發炎藥理學, 癌症藥理學, 腫瘤免疫微環境
Inflammation pharmacology; cancer pharmacology; tumor immune microenvironments
Publication
| NO | Publication |
|---|---|
| 1 | Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancer. Development of potent and selective tetrahydro-β-carboline-based HDAC6 inhibitors with promising activity against triple-negative breast cancer. |
| 2 | Unlocking the potential of novel tetrahydro-β-carboline-based HDAC6 inhibitors for colorectal cancer therapy: Design, synthesis and biological evaluation. Unlocking the potential of novel tetrahydro-β-carboline-based HDAC6 inhibitors for colorectal cancer therapy: Design, synthesis and biological evaluation. |
| 3 | Scutellaria barbata ameliorates acute respiratory distress syndrome by inhibiting neutrophil-mediated inflammatory responses. Scutellaria barbata ameliorates acute respiratory distress syndrome by inhibiting neutrophil-mediated inflammatory responses. |
| 4 | Discovery of a novel C2-functionalized chromen-4-one scaffold for the development of p38α MAPK signaling inhibitors to mitigate neutrophilic inflammatory responses. Discovery of a novel C2-functionalized chromen-4-one scaffold for the development of p38α MAPK signaling inhibitors to mitigate neutrophilic inflammatory responses. |
Project
| NO |
YEAR — Source — No — Type
Project Name
|
Duration |
|---|---|---|
| 1 |
115 — N 國科會(原科技部) — NSTC113-2320-B-037-032-MY3 — 1 個人型
探討台灣白及天然物對大腸直腸癌與嗜中性白血球交互作用之影響及其療效評估(3/3)( )
|
2026/08/01 ~ 2027/07/31 |
| 2 |
114 — N 國科會(原科技部) — NSTC113-2320-B-037-032-MY3 — 1 個人型
探討台灣白及天然物對大腸直腸癌與嗜中性白血球交互作用之影響及其療效評估(2/3)( )
|
2025/08/01 ~ 2027/07/31 |